Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation

Bone Marrow Transplant. 2017 Apr;52(4):646-649. doi: 10.1038/bmt.2016.338. Epub 2016 Dec 19.

J S Stenehjem^{1

2}, K B Smeland¹, K Murbraech³, H Holte⁴, S Kvaløy^{1

5}, T Wethal⁶, C E Kiserud¹, M B Lund^{5

7}

¹ Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
² Department of Research, Cancer Registry of Norway, Oslo, Norway.
³ Department of Cardiology, Oslo University Hospital, Oslo, Norway.
⁴ Department of Oncology, Oslo University Hospital, Oslo, Norway.
⁵ Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
⁶ Department of Cardiology, St Olavs University Hospital, Trondheim, Norway.
⁷ Department of Respiratory Medicine, Oslo University Hospital, Oslo, Norway.

No abstract available

Publication types